Application no. and date | 13893636.4 (espacenet) (Federated) (European Patent Register), 20130913 | Patent/reg. no. and date | DK/EP 3044234, 20200304 | Publication date | 20160720 | Priority no. and date | | EP pub. no. and date |
EP 3044234 20160720 | Effective date | | Applicant/owner | BeiGene Switzerland GmbH, c/o VISCHER AG Aeschenvorstadt 4
4051 Basel, CH | Applicant ref. no. | V47840DK00 | Inventor | SONG, Jing, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, LI, Kang, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, ZHANG, Tong, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, XU, Lanlan, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, LIU, Qi, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, PENG, Hao, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | Title | Anti-PD1-antistoffer og anvendelse deraf som terapeutika og diagnostika | Int. application no. | CN2013083467 | Int. publication no. | WO2015035606 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|